APA

Li X., Zeng W., Zhou Y., Ji Y., Li W., Zhang L., Guo Y., Feng D. & Zhang T. (2019). Neutrophil-To-Lymphocyte Ratio Predicted Long-Term Chemotherapy Benefits In Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer Patients Without Sensitive Mutations. : OncoTargets and therapy.

Chicago

Li Xing, Zeng Wei-Hua, Zhou Yu-Qi, Ji Yan-Ying, Li Wei-Zhan, Zhang Li-Yi, Guo Yue-Fei, Feng Ding-Yun and Zhang Tian-Tuo. 2019. Neutrophil-To-Lymphocyte Ratio Predicted Long-Term Chemotherapy Benefits In Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer Patients Without Sensitive Mutations. : OncoTargets and therapy.

Harvard

Li X., Zeng W., Zhou Y., Ji Y., Li W., Zhang L., Guo Y., Feng D. and Zhang T. (2019). Neutrophil-To-Lymphocyte Ratio Predicted Long-Term Chemotherapy Benefits In Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer Patients Without Sensitive Mutations. : OncoTargets and therapy.

MLA

Li Xing, Zeng Wei-Hua, Zhou Yu-Qi, Ji Yan-Ying, Li Wei-Zhan, Zhang Li-Yi, Guo Yue-Fei, Feng Ding-Yun and Zhang Tian-Tuo. Neutrophil-To-Lymphocyte Ratio Predicted Long-Term Chemotherapy Benefits In Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer Patients Without Sensitive Mutations. : OncoTargets and therapy. 2019.